We are live on ! Find out more
NFC

Northeast Financial Consultants Portfolio holdings

AUM $2.45B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+0.54%
1 Year Est. Return
+15.14%
3 Year Est. Return
+63.77%
5 Year Est. Return
+108.46%
10 Year Est. Return
+198.58%
AUM
$1.5B
AUM Growth
+$13M
Cap. Flow
+$8.71M
Cap. Flow %
0.58%
Top 10 Hldgs %
45.93%
Holding
363
New
16
Increased
94
Reduced
75
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 9.41%
2 Financials 9.16%
3 Technology 8.36%
4 Communication Services 5.99%
5 Consumer Discretionary 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXPD icon
326
Expeditors International
EXPD
$24B
$214K 0.01%
1,800
TLT icon
327
iShares 20+ Year Treasury Bond ETF
TLT
$40.6B
$213K 0.01%
1,473
-324
-18% -$48.1K
CHWY icon
328
Chewy
CHWY
$9.15B
$211K 0.01%
3,100
MGNX icon
329
MacroGenics
MGNX
$256M
$209K 0.01%
10,000
NTRS icon
330
Northern Trust
NTRS
$35B
$207K 0.01%
1,920
ZM icon
331
Zoom
ZM
$30.8B
$204K 0.01%
779
ARKF icon
332
ARK Blockchain & Fintech Innovation ETF
ARKF
$758M
$203K 0.01%
4,106
-475
-10% -$24.8K
CARR icon
333
Carrier Global
CARR
$52B
$202K 0.01%
+3,901
New +$210K
FTI icon
334
TechnipFMC
FTI
$29.5B
$200K 0.01%
26,600
IMGN
335
DELISTED
Immunogen Inc
IMGN
$195K 0.01%
34,315
CVET
336
DELISTED
Covetrus, Inc. Common Stock
CVET
$193K 0.01%
10,616
NAD icon
337
Nuveen Quality Municipal Income Fund
NAD
$2.75B
$171K 0.01%
10,959
CMRX
338
DELISTED
Chimerix, Inc.
CMRX
$160K 0.01%
+25,802
New +$177K
KG
339
Kestrel Group
KG
$66.3M
$156K 0.01%
2,476
AUTL
340
Autolus Therapeutics
AUTL
$564M
$146K 0.01%
+22,215
New +$140K
AGEN
341
Agenus
AGEN
$311M
$145K 0.01%
1,410
OCUL icon
342
Ocular Therapeutix
OCUL
$2.25B
$140K 0.01%
+14,015
New +$157K
MYN icon
343
BlackRock MuniYield New York Quality Fund
MYN
$376M
$138K 0.01%
10,000
KNSA icon
344
Kiniksa Pharmaceuticals
KNSA
$6.1B
$130K 0.01%
+11,440
New +$149K
LRMR icon
345
Larimar Therapeutics
LRMR
$454M
$117K 0.01%
+10,105
New +$121K
ALT icon
346
CALL
Altimmune
ALT
$570M
$113K 0.01%
10,000
ATAXZ
347
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$95K 0.01%
16,000
CLSD
348
DELISTED
Clearside Biomedical
CLSD
$78K 0.01%
867
+200
+30% +$17.7K
LMACW
349
DELISTED
Liberty Media Acquisition Corporation Warrants
LMACW
$76K 0.01%
52,135
+13,632
+35% +$24.5K
ETWO.WS
350
DELISTED
E2open Parent Holdings, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
ETWO.WS
$71K ﹤0.01%
24,500

Similar funds

Northeast Financial Consultants's Q3 2021 Portfolio in Review

As of Q3 2021, Northeast Financial Consultants held 363 positions worth $1.5B, up 0.87% from $1.49B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Northeast Financial Consultants's Q3 2021 filing shows 16 new, 94 increased, 75 reduced and 11 closed positions. Its largest new stake was Highland Transcend Partners I Corp.: 301,990 shares worth $3M. The largest sale was Brookfield, an estimated $9.55M.

By sector, the portfolio is most concentrated in Healthcare at 9.4% of assets, up from 9.2% a quarter earlier, followed by Financials and Technology.

  • Northeast Financial Consultants's largest Q3 2021 buy was Highland Transcend Partners I Corp.: 301,990 shares worth $3M.
  • Northeast Financial Consultants added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $19.3M increase.
  • Northeast Financial Consultants's biggest Q3 2021 reduction was Brookfield, cutting an estimated $9.55M.
  • Northeast Financial Consultants fully exited Texas Instruments in Q3 2021, selling an estimated $2.59M.
  • Northeast Financial Consultants's ten largest holdings make up 46% of its $1.5B portfolio in Q3 2021.
  • Northeast Financial Consultants opened 16 new positions and closed 11 in Q3 2021.
  • Northeast Financial Consultants's portfolio value rose 0.87% quarter-over-quarter to $1.5B.

Based on Northeast Financial Consultants's 13F filing for Q3 2021, filed 15 Nov 2021.